We are live on ! Find out more
OPTN

OptiNose
OPTN

Delisted

OPTN was delisted on the 20th of May, 2025.

Back to rankings

49 hedge funds and large institutions have $166M invested in OptiNose in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 18 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 3

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

49% more capital invested

Capital invested by funds: $112M → $166M (+$54.5M)

11% more funds holding

Funds holding: 44 → 49 (+5)

0% less ownership

Funds ownership: 3.68% → 3.67% (-0%)

22% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 18

Holders
49
Holders Change
+5
Holders Change %
+11.36%
% of All Funds
0.83%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.07%
New
8
Increased
14
Reduced
18
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
EI
EAM Investors
California
+$652K
2
KCM
Kingdon Capital Management
New York
+$515K
3
EIP
Easterly Investment Partners
Massachusetts
+$326K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$271K
5
OM
Opaleye Management
Massachusetts
+$223K

Top Sellers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
-$760K
2
Millennium Management
Millennium Management
New York
-$546K
3
Morgan Stanley
Morgan Stanley
New York
-$408K
4
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$169K
5
Goldman Sachs
Goldman Sachs
New York
-$156K
Name Holding Trade Value Shares
Change 		Change in
Stake
Simplex Trading
51
Simplex Trading
Illinois
– +$405 +11 New
1 2
3

OPTN Hedge Fund Activity: Q2 2022 in Review

49 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in OptiNose (OPTN) for Q2 2022, worth a combined $166M — up 49% from $112M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new OPTN positions and 3 closed out — a net gain of 5 holders — while 14 added to existing stakes and 18 trimmed.

The largest buyer was EAM Investors, opening a new position worth an estimated $652K. The largest seller was Stonepine Capital Management, cutting an estimated $760K.

  • 49 institutional investors held OptiNose (OPTN) as of Q2 2022, up from 44 in Q1 2022.
  • Funds reported $166M of OptiNose stock for Q2 2022, up 49% quarter-over-quarter.
  • 8 funds opened new OptiNose positions in Q2 2022 and 3 closed out, a net change of +5 holders.
  • The largest OptiNose buyer in Q2 2022 was EAM Investors, an estimated $652K added.
  • The largest OptiNose seller in Q2 2022 was Stonepine Capital Management, an estimated $760K sold.

Based on aggregated 13F filings for Q2 2022.